Sphingosine-1-phosphate signaling in human submandibular cells

Journal of Dental Research

Volumn 89, Issue 10, 2010, Pages 1148-1153

  Seo, J ^a   Koo, N Y ^a   Choi, W Y ^a   Kang, J A ^a   Min, J H ^a   Jo, S H ^b   Lee, S J ^a   Oh, S B ^a   Kim, J S ^a   Lee, J H ^a   Choi, S Y ^a   Park, K ^a  

^a School of Dentistry   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

intracellular calcium; receptor; sphingosine kinase; sphingosine 1 phosphate; submandibular gland

Indexed keywords

1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 AMINOETHOXYDIPHENYLBORANE; 2 PYRROLIDONE DERIVATIVE; 2-AMINOETHOXYDIPHENYL BORATE; BORON DERIVATIVE; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; ESTRANE DERIVATIVE; FAS ANTIGEN; INTERLEUKIN 6; LYSOPHOSPHOLIPID; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL CULTURE; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BORON COMPOUNDS; CALCIUM SIGNALING; CARBACHOL; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHOLINERGIC AGONISTS; ESTRENES; FEMALE; HUMANS; INTERLEUKIN-6; LYSOPHOSPHOLIPIDS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PYRROLIDINONES; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; SPHINGOSINE; SUBMANDIBULAR GLAND; TYPE C PHOSPHOLIPASES;

EID: 78049427228     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510376044     Document Type: Article

References (35)

1. Ambudkar IS (2000). Regulation of calcium in salivary gland secretion. Crit Rev Oral Biol Med 11: 4-25.
2. Billich A., Bornancin F., Dévay P., Mechtcheriakova D., Urtz N., Baumruker T. (2003). Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 278: 47408-47415.
3. Brinkmann V., Davis MD, Heise CE, Albert R., Cottens S., Hof R., et al. (2002). The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277: 21453-21457.
4. Chalfant CE, Spiegel S. (2005). Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118 (Pt 20). 4605-4612.
5. Chiba K. (2005). FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol Ther 108: 308-319.
6. Choi SY, Choi BH, Suh BC, Chae HD, Kim JS, Shin MJ, et al. (2001). Potentiation of PGE2-mediated cAMP production during neuronal differentiation of human neuroblastoma SK-N-BE(2)C cells. J Neurochem 79: 303-310.
7. Choi SY, Li J., Jo SH, Lee SJ, Oh SB, Kim JS, et al. (2006). Desipramine inhibits Na+/H+ exchanger in human submandibular cells. J Dent Res 85: 839-843.
8. Dev KK, Mullershausen F., Mattes H., Kuhn RR, Bilbe G., Hoyer D., et al. (2008). Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol Ther 117: 77-93.
9. Don AS, Martinez-Lamenca C., Webb WR, Proia RL, Roberts E., Rosen H. (2007). Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. J Biol Chem 282: 15833-15842.
10. Fonseca JE, Santos MJ, Canhão H., Choy E. (2009). Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 36: 837-842.
11. Gardell SE, Dubin AE, Chun J. (2006). Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med 12: 65-75.
12. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P., Kersey JH, Dosik H., et al. (1973). In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423.
13. Grynkiewicz G., Poenie M., Tsien RY (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
14. Guggenheimer J., Moore PA (2003). Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 134: 61-69.
15. Ishii I., Fukushima N., Ye X., Chun J. (2004). Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 73: 321-354.
16. Kasinathan C., William S., Vaidyanathan S., Leventhal J. (1995). Effect of lipids on glycoprotein sulphotransferase activity in rat submandibular salivary glands. Arch Oral Biol 40: 433-438.
17. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. (2009). Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 182: 3540-3547.
18. Lipsky PE (2006). Interleukin-6 and rheumatic diseases. Arthritis Res Ther 8 (Suppl 2). 4.
19. Liu XB, Masago R., Kong L., Zhang BX, Masago S., Vela-Roch N., et al. (2000). G-protein signaling abnormalities mediated by CD95 in salivary epithelial cells. Cell Death Differ 7: 1119-1126.
20. Maceyka M., Sankala H., Hait NC, Le Stunff H., Liu H., Toman R. et al. (2005). SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280: 37118-37129.
21. Manoussakis MN, Kapsogeorgou EK (2007). The role of epithelial cells in the pathogenesis of Sjögren's syndrome. Clin Rev Allergy Immunol 32: 225-230.
22. McGeachy MJ, Bak-Jensen KS, Chen Y., Tato CM, Blumenschein W., McClanahan T., et al. (2007). TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat Immunol 8: 1390-1397.
23. Meijer JM, Pijpe J., Bootsma H., Vissink A., Kallenberg CG (2007). The future of biologic agents in the treatment of Sjögren's syndrome. Clin Rev Allergy Immunol 32: 292-297.
24. Mezosi E., Wang SH, Utsugi S., Bajnok L., Bretz JD, Gauger PG, et al. (2005). Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells. Mol Endocrinol 19: 804-811.
25. Pyne S., Lee SC, Long J., Pyne NJ (2009). Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease. Cell Signal 21: 14-21.
26. Rosen H., Goetzl EJ (2005). Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5: 560-570.
27. Salmaso C., Bagnasco M., Pesce G., Montagna P., Brizzolara R., Altrinetti V., et al. (2002). Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Ann NY Acad Sci 966: 496-501.
28. Sekiguchi M., Iwasaki T., Kitano M., Kuno H., Hashimoto N., Kawahito Y., et al. (2008). Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome. J Immunol 180: 1921-1928.
29. Shirasuna K., Sato M., Miyazaki T. (1981). A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer 48: 745-752.
30. Sugiya H., Furuyama S. (1990). Sphingosine increases inositol trisphosphate in rat parotid acinar cells by a mechanism that is independent of protein kinase C but dependent on extracellular calcium. Cell Calcium 11: 469-475.
31. Sugiya H., Furuyama S. (1991). Sphingosine stimulates calcium mobilization in rat parotid acinar cells. FEBS Lett 286: 113-116.
32. Sun X., Mörk AC, Helmke RJ, Martinez JR, Zhang GH (1999). Effects of serum on calcium mobilization in the submandibular cell line A253. J Cell Biochem 73: 458-468.
33. Turner RJ, Sugiya H. (2002). Understanding salivary fluid and protein secretion. Oral Dis 8: 3-11.
34. Xu SZ, Muraki K., Zeng F., Li J., Sukumar P., Shah S., et al. (2006). A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ Res 98: 1381-1389.
35. Zhang Y., Xu G., Zhang L., Roberts AI, Shi Y. (2008). Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma. J Immunol 181: 190-196.